Taq Ortho is developing novel focal fixation augments designed to address critical challenges in implant placement and long-term survival.
Taq Ortho's mission is to be the leading provider of focal fixation augments in orthopedics and total joint surgery. We leverage advanced digital fabrication to develop novel hybrid fixation devices that improve placement accuracy and long-term outcomes.
As the total joint market expands globally with broadening indications, surgeons need new tools to address persistent challenges in implant fixation. Taq Ortho is building that solution.
Novel augments combining biological fixation with enhanced mechanical interlock for improved implant stability at critical interfaces.
A modular system of constructs designed for versatility across multiple joint applications and clinical scenarios.
Developed by practicing orthopedic surgeons and experienced device engineers to integrate into existing surgical workflows.
Leveraging advanced additive manufacturing to produce implant architectures not achievable through conventional methods.
Targeting fixation challenges at the interfaces most prone to failure — where no adequate solutions currently exist in the standard of care.
Providing surgeons with options for corrective positioning when bone loss or over-resection occurs during arthroplasty procedures.
A seasoned team of surgeons, engineers, and industry professionals with decades of combined experience in orthopedic device innovation.
Surgeon, engineer, and serial entrepreneur with 35 years in complex total joint surgery. BS in Mechanical Engineering and Biology from Stanford, MD from Harvard Medical School. Founded multiple medtech companies including Invuity (acquired by Stryker) and Bespoke Innovations (acquired by 3D Systems). Co-founded the NSF Center for Biophotonics. Holds 88 issued US patents.
LinkedIn →Healthcare strategist and entrepreneur with extensive experience building, investing in, and advising life science, biotech, and medtech companies. BA in Neuroscience and Healthcare Management and MS in Biotechnology and Engineering Entrepreneurship from the University of Pennsylvania. CSO at Permanentech, Director of Corporate Development at TPMG Innovations.
LinkedIn →Combines deep engineering expertise with 20+ years of innovation and product development in the medical device field at Zimmer Biomet. Portfolio includes numerous patented inventions in advanced surgical instrumentation, ACL reconstruction, porous metal implants, and joint arthroplasty systems.
LinkedIn →Executive, innovator, and venture investor with over 25 years in the biopharmaceutical industry. Founded and led Pharma R&D and Health Analytics for PwC, co-founded Nextec Neuroscience. Serves on advisory boards of Ocean Genomics and the Rockefeller Neuroscience Institute. Degrees from Brooklyn College and Columbia University.
LinkedIn →Combining technology and ingenuity to address unmet clinical needs. reach out to learn more about taq ortho.
Whether you're a surgeon, investor, or industry partner, we'd love to hear from you.
Taq Ortho, LLC
San Francisco, CA
Est. 2021